Bireociclib Plus Fulvestrant Shows Strong Efficacy in HR+/HER2- Advanced Breast Cancer: Final BRIGHT-2 Phase 3 Results Published in JAMA Oncology 1
Xuanzhu Biopharmaceutical Announces Final Results of BRIGHT-...
Sign in to continue:
Xuanzhu Biopharmaceutical Announces Final Results of BRIGHT-...
Greenland Hong Kong Holdings Issues Significant Profit Warni...
China Industrial Securities International Financial Group - ...
Net-A-Go Technology Company Limited Issues Profit Warning fo...
Digital China Holdings Limited Issues Positive Profit Alert ...
Fujian Haixi Pharmaceuticals Announces Major Clinical Progre...
Sundy Service Group Co. Ltd Issues Significant Profit Warnin...
Sichuan Kelun-Biotech Biopharmaceutical Announces IND Approv...
Tian Ge Interactive Holdings Limited Issues Profit Warning f...
Key Highlights Significant Increase in Loss: The Group ...